Mobia Medical names Reza Zadno to board as independent director

PUBT · 1d ago
Mobia Medical names Reza Zadno to board as independent director
  • Mobia Medical named Reza Zadno to its board as an independent director, effective July 14, 2026.
  • Zadno will join the compensation committee.
  • He previously served as CEO of PROCEPT BioRobotics from February 2020 to September 2025, leading its 2021 IPO.
  • He also led Avedro as CEO, a public ophthalmology company later acquired by Glaukos.
  • Zadno is an operating partner at Jolt Capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mobia Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607151605PRIMZONEFULLFEED9762943) on July 15, 2026, and is solely responsible for the information contained therein.